Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Next revisionBoth sides next revision
home:pathogenesis:vitamind:low25d [07.13.2011] – [Anomalies] paulalberthome:pathogenesis:vitamind:low25d [08.29.2012] – [Anomalies] paulalbert
Line 73: Line 73:
 ===== Anomalies ===== ===== Anomalies =====
  
 +  
 +  * **mortality in the Danish population** – A 2012 study
   * **risk of breast cancer** – In a 2011 study of nurses who were predominantly premenopausal, circulating 25-D levels were not significantly associated with breast cancer risk.   * **risk of breast cancer** – In a 2011 study of nurses who were predominantly premenopausal, circulating 25-D levels were not significantly associated with breast cancer risk.
   * **risk of prostate cancer** – In a 2008 nested case-control study appearing in //Journal of the National Cancer Institute//, Ahn //et al.// found that patients with the lowest levels of 25-D also had the lowest risk of prostate cancer.(({{pubmed>long:18505967}}))    * **risk of prostate cancer** – In a 2008 nested case-control study appearing in //Journal of the National Cancer Institute//, Ahn //et al.// found that patients with the lowest levels of 25-D also had the lowest risk of prostate cancer.(({{pubmed>long:18505967}})) 
Line 82: Line 84:
  
 ===== Notes and comments ===== ===== Notes and comments =====
-TECHEDIT+
  
 {{:home:pathogenesis:vitamind:screen_shot_2010-11-15_at_11.01.45_am.png|}} {{:home:pathogenesis:vitamind:screen_shot_2010-11-15_at_11.01.45_am.png|}}
home/pathogenesis/vitamind/low25d.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.